European Neuropsychopharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 8.1 | Q1 | 95.9% | 2.334 | Q1 | 96.4% |
| 2024 | 6.7 | Q1 | 94.1% | 1.934 | Q1 | 95.0% |
| 2023 | 6.1 | Q1 | 92.0% | 1.756 | Q1 | 94.4% |
| 2022 | 5.6 | Q1 | 83.5% | 1.442 | Q1 | 92.6% |
| 2021 | 5.4 | Q2 | 79.9% | 1.324 | Q1 | 91.5% |
| 2020 | — | — | 1.603 | Q1 | 93.3% | |
| 2019 | — | — | 1.652 | Q1 | 93.8% | |
| 2018 | — | — | 1.911 | Q1 | 94.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1873-7862
ISSN
0924-977X
region
Western Europe
coverage
1990-2026